hindustan bio sciences has published its audited standalone financial results for the fourth quarter and financial year ended March 31, 2026. The company released the financial statements pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The results were published in Hitech Edition (English) on June 2, 2026, and in The Praja Palana (Telugu) on June 1, 2026. The audited financial results and statements are accessible on the websites of BSE Limited and the company.

Publication Details

The company intimated the stock exchange regarding the publication of these results. The intimation, signed by Managing Director Venkata Rama Mohan Raju Jampana, confirmed the dissemination of the financial data.

Accessing the Results

The audited standalone financial results and financial statements can be accessed on the BSE Limited website and the official website of Hindustan Bio Sciences Limited. A specific QR code has also been provided for direct access to the financial results document.

Hindustan Bio Sciences Limited has filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, with the stock exchanges. The report, dated May 16, 2026, was issued by Mr. V B S S Prasad, a Practicing Company Secretary, following a review of the company's adherence to statutory provisions and good corporate practices.

Compliance Overview

The review confirmed that hindustan bio sciences complied with the provisions of the SEBI (LODR) Regulations, 2015, and other applicable guidelines during the review period. The examination included the company's books, papers, minutes books, forms, returns, and other records. The report also verified compliance with the Securities Contracts (Regulation) Act, 1956, and the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Findings

The report detailed the compliance status across various regulatory requirements. It noted that the company has adopted and updated all applicable policies under SEBI regulations with board approval. Furthermore, the company maintains a functional website with timely dissemination of required documents.

Additional Disclosures

The report stated that the company does not have any subsidiary companies during the period under review. It also confirmed that no actions were taken against the listed entity, its promoters, or directors by SEBI or the Stock Exchanges. M/s. VASG & ASSOCIATES, Chartered Accountant, continued as the statutory auditor for the term ending 2026-27, with no resignation occurring during the financial year.